Author:
Ke Yao-hua,Yue Hua,He Jin-wei,Liu Yu-juan,Zhang Zhen-lin
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference17 articles.
1. Ralston SH, Langston AL, Reid IR . Pathogenesis and management of Paget's disease of bone. Lancet 2008; 372: 155–63.
2. Zhang ZL, Meng XW, Xing XP, Wang O, Xia WB, Li M, et al. Prospective study of pamidronate disodium in treatment of Paget's disease of bone. Zhonghua Yi Xue Za Zhi 2003; 83: 1653–6.
3. Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, et al. Mutations in TNFRSF11A, affecting the signal peptide RANK, cause familial expansile osteolysis. Nat Genet 2000; 24: 45–8.
4. Nakatsuka K, Nishizawa Y, Ralston SH . Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 2003; 18: 1381–5.
5. Good DA, Busfield F, Fletcher BH, Lovelock PK, Duffy DL, Kesting JB, et al. Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 2004; 35: 277–8.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献